Closed |
S0119 |
Gemcitabine/Irinotecan Untreated Extensive SCLC |
1/1/2002 |
2/15/2003 |
100% |
|
Published
|
Closed |
S0502 |
GIST Ph III imatinib with or without bevacizumab |
4/15/2008 |
10/1/2009 |
2% |
|
Published
|
Closed |
S0001 |
Glioblastoma Multiforme/Gliosarcoma |
9/1/2001 |
11/15/2005 |
46% |
|
Published
|
Closed |
S9812 |
GU/Prostate |
6/15/1999 |
6/1/2001 |
100% |
|
Published
|
Closed |
S9917 |
GU/Prostate (HGPIN) |
2/1/2000 |
11/1/2006 |
53% |
|
Published
|
Closed |
S9706 |
HD CTX followed by FLUDARA in B-Cell CLL |
9/15/1997 |
3/1/1999 |
100% |
|
Published
|
Closed |
SWOG-8465 |
High Dose Cisplatinum in the Treatment of Osteogenic and Soft Tissue Sarcoma |
8/17/1984 |
7/15/1987 |
|
|
Published
|
Closed |
SWOG-9011 |
High Dose Etoposide, Cyclophosphamide and Either Fractionated Total Body Irradiation or Carmustine Combined with Autologous Bone Marrow Rescue for Refractory or Relapsed Hodgkin's Disease |
4/15/1990 |
12/1/1995 |
90% |
|
Published
|
Closed |
SWOG-8942 |
High Dose Etoposide, Cyclophosphamide and Either Fractionated Total Body Irradiation or Carmustine Combined with Autologous Bone Marrow Rescue for Refractory or Relapsed Non-Hodgkin's Lymphoma |
3/1/1990 |
12/15/1994 |
100% |
|
Published
|
Closed |
S0008 |
High Dose IFN vs. Cis/Vinblastine/DTIC + IL-2 & IFN in High Risk Melanoma |
8/1/2000 |
11/15/2007 |
90% |
|
Published
|
Closed |
SWOG-9415 (INT-0153) (CALGB-9498) (ECOG-S9415) (NCCTG-S9415) |
High Risk Resectable Colon |
12/1/1994 |
12/15/1999 |
71% |
|
Published
|
Closed |
SWOG-8562 |
High-Dose Cisplatin in Hypertonic Saline for the Treament of Metastatic or Recurrent Malignant Melanoma |
1/3/1986 |
2/15/1990 |
|
|
Published
|
Closed |
SWOG-9341 |
High-Dose Ifosfamide (HDI) with Mesna and Granulocyte-Colony Stimulating Factor (rhG-CSF) in Unresectable Malignant Mesothelioma |
9/15/1994 |
9/15/1996 |
100% |
|
Published
|
Closed |
SWOG-774/775 |
Hodgkin's Disease: Remission Induction with Mustargen, Oncovin, Prednisone and Procarbazine + Bleomycin (MOPP#4) |
7/20/1971 |
8/23/1974 |
|
|
Published
|
Closed |
S0517 |
HODGKIN'S: SAHA for Recurrent or Primary Refractory Hodgkin's Lymphoma |
9/15/2005 |
8/1/2007 |
77% |
|
Published
|
Closed |
S9811 |
Hydroxyurea |
11/15/1998 |
6/1/2005 |
66% |
|
Published
|
Closed |
S0026 |
IFN & Thalidomide in Disseminated Malignant Melanoma |
11/1/2001 |
5/1/2003 |
62% |
|
Published
|
Closed |
SWOG-8731 |
Ifosfamide and Mesna in Malignant Mesothelioma |
3/1/1988 |
7/15/1989 |
|
|
Published
|
Closed |
SWOG-8091 |
In Vitro Chemotherapy Sensitivity Testing of Leukemic Stem Cells Using a Cloning Assay, Ancillary. |
10/23/1980 |
4/1/1987 |
|
|
Published
|
Closed |
SWOG-8571 |
Induction Chemotherapy With High-Dose Cyclophosphamide for Poor Prognosis, Disseminated Breast Cancer, with Radiation Therapy in Complete Responders |
4/15/1986 |
1/1/1988 |
|
|
Published
|